Evidence map›Paper›PMID 30345640›Full record

ArticleAddiction (Abingdon, England)2019

Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.

Brantley P Jarvis, August F Holtyn, Shrinidhi Subramaniam, D Andrew Tompkins, Emmanuel A Oga, George Bigelow, Kenneth Silverman

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Brantley P JarvisPsychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
August F HoltynPsychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shrinidhi SubramaniamDepartment of Psychology and Child Development, California State University, Stanislaus, Turlock, CA, USA.
D Andrew TompkinsDepartment of Psychiatry, University of California San Francisco School of Medicine Ringgold standard institution, San Francisco, CA, USA.
Emmanuel A OgaCenter for Applied Public Health Research, RTI International, Rockville, MD, USA.
George BigelowPsychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kenneth SilvermanPsychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NaltrexoneOpioid-Related DisordersHumansNarcotic AntagonistsNaltrexoneNarcotic AntagonistsExtended-releaseheroininjectablemedication-assisted treatmentnaltrexoneopioid use disorderprescription opioids

Identifiers

PMID30345640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.